Inhibitors of JNK have been used as a therapeutic strategy for neuroprotection in the retina [60], and multitargeting inhibitor protein kinases have been proposed as the most promising strategy to treat Alzheimer’s disease [61]. The gene discussed is MAPK8; the disease is early-onset autosomal dominant Alzheimer disease.